Hubei Biocause Heilen Pharmaceutical (301211.SZ): Ibuprofen sustained-release capsules obtain drug registration certificate.

Hubei Biocause Heilen Pharmaceutical (301211.SZ) announced that the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration, involving the product: "Ibuprofen Sustained-Release Capsules". The company's Ibuprofen Sustained-Release Capsules have obtained the drug registration certificate from the National Medical Products Administration, indicating that the company has the qualification to sell this drug in the domestic market. This further enriches the company's product line and signifies a new breakthrough in the company's "raw material drug formulation integration" strategy.